Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The significance of the Sir William Dunn School of Pathology's place in history was once more reaffirmed when the development of antibiotics won the accolade of Britain’s Greatest Invention in a live TV broadcast on BBC2 on 15 June 2017.

Television journalist and presenter Angela Rippon championed antibiotics as the country’s greatest invention stating they have saved over 200 million lives to date. In a supplementary pre-recorded segment, she visited the Dunn School to find out about the history of the development of penicillin here in Oxford and the drug's crucial lifesaving role in World War II.

The development of penicillin heralded the birth of the antibotics era and an array of antibacterial drugs. Having suffered tuberculosis as a child Angela Rippon owes her life to antibiotics and claimed: “Antibiotics are the saviour of the human race.”

Read more (Sir William Dunn School of Pathology website) 

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.